Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate - 31/03/21

Zhenchuan Song, MD ^{a, ⁎} , Fuguo Tian, MS ^b, Shuo Feng, MS ^a, Lingzi Shi, BS ^a, Xiaoqing Chen, BS ^a, Xiaohan Liu, BS ^a, Meiqi Wang, MS ^a, Yixin Qi, MD ^a, Tianli Hui, MD ^a, Yuming Fu, PhD ^{c, d, ⁎}

^a Breast Center, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, China 

^b Breast Center, Shanxi Tumor Hospital, Taiyuan, China 

^c School of Biological Science and Medical Engineering, Beihang University, Beijing, China 

^d Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China 

^∗Correspondence to: Zhenchuan Song, MD, Breast Center, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, No.169 Tianshan Street, Shijiazhuang, China 050035; andBreast CenterHebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor HospitalNo.169 Tianshan StreetShijiazhuang050035China^∗Yuming Fu, PhD, School of Biological Science and Medical Engineering, Beihang University, No.37 Xueyuan Road, Beijing, China 100191School of Biological Science and Medical EngineeringBeihang UniversityNo.37 Xueyuan RoadBeijing100191China